GENMAB A/S (GMAB) Form 6-K — May 29, 2026
Genmab A/S filed a Form 6-K disclosing that Michael Kavanagh, a member of the Board of Directors, sold 526 shares of the company's stock on May 29, 2026. The shares were sold at a price of DKK 1,734.75 per share on the NASDAQ Copenhagen exchange, in compliance with EU Market Abuse Regulation reporting requirements.
Key figures
- Shares sold
- 526
- Transaction date
- 2026-05-29
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.